MiRNA Sequencing Assay Market is Slated to Witness Tremendous Growth in Coming Years

MiRNA Sequencing Assay Market

The MiRNA Sequencing Assay Market sequencing assay was USD 594.16 billion in 2022 and is projected to experience a compound annual growth rate (CAGR) of 12% during the forecast period. The increasing adoption of Next Generation Sequencing (NGS) technologies for accurate and reliable disease detection, along with advancements in bioinformatics tools for data analysis, are key factors contributing to the growth of market revenue.

MiRNA sequencing assay is a method used to sequence small RNA molecules called microRNAs, which play a crucial role in gene regulation and expression. This technique involves isolating and purifying these tiny RNA molecules from tissues or cells, followed by their conversion into complementary Deoxyribonucleic Acid (DNA) using reverse transcription. Subsequently, the cDNA is amplified and sequenced using NGS technologies, generating high-throughput sequencing data that can be analyzed using bioinformatics tools.

Get a sample of the report @ https://www.reportsanddata.com/download-free-sample/6157 

The increasing prevalence of cancer and other chronic diseases such as cardiovascular diseases, neurological disorders, and metabolic disorders is driving the demand for precise and reliable diagnostic tools. MicroRNAs have been recognized as significant biomarkers for various diseases, and analyzing them through the MiRNA sequencing assay can provide critical insights into diagnosis, prognosis, and treatment efficacy. For example, the American Cancer Society predicts 1.9 million new cases of cancer and 608,570 cancer-related deaths in the United States alone in 2022.

Furthermore, the growing utilization of NGS technologies for sequencing and analyzing genomic data is contributing to the demand for MiRNA sequencing assay. NGS technologies offer several advantages over traditional sequencing techniques, including high-throughput sequencing, improved accuracy and sensitivity, and reduced sequencing time and cost. With NGS technology becoming more accessible and affordable in both research and clinical settings, the adoption of MiRNA sequencing assay is expected to increase.

Competitive Landscape:

  • Illumina, Inc.
  • Thermo Fisher Scientific Inc.
  • BGI Genomics
  • Becton, Dickinson and Company (BD)
  • Takara Bio Inc.
  • Sigma-Aldrich Corporation
  • Agilent Technologies, Inc.
  • PerkinElmer, Inc.
  • F. Hoffmann-La Roche AG

By Product Type Outlook

  • Library Preparation Kits
  • Sequencing Services
  • Reagents & Consumables
  • Instruments
  • Software & Services

By Technology Outlook

  • Sequencing by Synthesis (SBS)
  • Ion Semiconductor Sequencing
  • Single-Molecule Real-Time (SMRT) Sequencing
  • Nanopore Sequencing
  • Others

Regional analysis provides insights into key trends and demands in each major country that can affect market growth in the region.

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, U.K., Italy, France, BENELUX, Rest of Europe)
  • Asia Pacific (China, India, Japan, South Korea, Rest of APAC)
  • Latin America (Brazil, Rest of LATAM)
  • Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Request a customized copy of the report @ https://www.reportsanddata.com/request-customization-form/6157 

Thank you for reading our report. We also offer customized report as per client requirement. Kindly connect with us to know more about customization plan and our team will offer you the altered report.

Get Explore Latest Research Report by Reports and Data:

Hysteroscope Market @ https://www.journalofbusinessnews.com/article/635356402-hysteroscope-market-growth-forecasted-cagr-of-4-7-usd-374-14-million-in-2030-reports-and-data

Hysteroscope Market @ https://www.worldpostreporter.com/article/635356402-hysteroscope-market-growth-forecasted-cagr-of-4-7-usd-374-14-million-in-2030-reports-and-data

Hysteroscope Market @ https://www.montserratdailynews.com/article/635356402-hysteroscope-market-growth-forecasted-cagr-of-4-7-usd-374-14-million-in-2030-reports-and-data

Hysteroscope Market @ https://www.smartsbusinesswire.com/article/635356402-hysteroscope-market-growth-forecasted-cagr-of-4-7-usd-374-14-million-in-2030-reports-and-data

Hysteroscope Market @ https://www.globalmediawatch.com/article/635356402-hysteroscope-market-growth-forecasted-cagr-of-4-7-usd-374-14-million-in-2030-reports-and-data

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, TouchPoints, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provide our clients with the ability to secure an edge over their respective competitors.

Contact Us:

John W

Head of Business Development

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com

Back to top button